It helped to pioneer cardiovascular interventional devices in China, and was a model for medical technology collaboration between Hong Kong and the Chinese mainland. Now, 22-year-old Chinese medical device maker OrbusNeich Medical Group Holdings Ltd. wants to move to another new frontier with plans for a Hong Kong IPO.
作者陳嘉儀，本文僅代表個人觀點
您已閱讀4%（335字），剩余96%（8284字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。